FP
Flagship Pioneering
Venture CapitalActiveFlagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability.
213
Investments
56
Exits
$2.6B
AUM
26.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Flagship Pioneering.
Investment Thesis & Strategy
Flagship Pioneering invests in early-stage biotech and healthcare companies with the potential to transform human health and sustainability. They focus on conceiving, creating, and growing first-in-category ventures.
Investment Activity
Deals per year over the last 7 years
1
20155
20161
20171
20180
20193
20201
2021Portfolio Companies
Selected investments from their portfolio of 213 companies
L
Laronde
Biotech · Series A, 2021
S
Senda Biosciences
Biotech · Series A, 2020
G
Generate Biomedicines
Biotech · Series A, 2020
O
Omega Therapeutics
Biotech · Series A, 2020
T
Tessera Therapeutics
Biotech · Series A, 2018
C
Cellarity
Biotech · Series A, 2017
I
Inari Agriculture
Biotech · Series A, 2016
A
Axcella Health
Biotech · Series A, 2016
K
Kaleido Biosciences
Biotech · Series A, 2016
E
Evelo Biosciences
Biotech · Series A, 2016
C
Codiak BioSciences
Biotech · Series A, 2016
D
Denali Therapeutics
Biotech · Series A, 2015
Frequently Asked Questions
Flagship Pioneering focuses on Series A, Series B, Series C+ stage investments.